Literature DB >> 28794556

Keratin 17 Mutations in Four Families from India with Pachyonychia Congenita.

Manoj Agarwala1, Pankaj Salphale1, Dincy Peter1, Neil J Wilson2, Susanne Pulimood1, Mary E Schwartz3, Frances J D Smith2.   

Abstract

Pachyonychia congenita (PC) is a rare autosomal dominant genetic skin disorder due to a mutation in any one of the five keratin genes, KRT6A, KRT6B, KRT6C, KRT16, or KRT17. The main features are palmoplantar keratoderma, plantar pain, and nail dystrophy. Cysts of various types, follicular hyperkeratosis, oral leukokeratosis, hyperhidrosis, and natal teeth may also be present. Four unrelated Indian families presented with a clinical diagnosis of PC. This was confirmed by genetic testing; mutations in KRT17 were identified in all affected individuals.

Entities:  

Keywords:  Cysts; keratin; keratin mutation; nail dystrophy; pachyonychia congenita; palmoplantar keratoderma; plantar pain

Year:  2017        PMID: 28794556      PMCID: PMC5527726          DOI: 10.4103/ijd.IJD_321_16

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


What was known? Pachyonychia congenita (PC) is characterized by plantar keratoderma, plantar pain, and nail dystrophy Other associated features include cysts, follicular hyperkeratosis, oral leukokeratosis, hyperhidrosis, and natal teeth PC is due to a mutation in any one of the five keratin genes, KRT6A, KRT6B, KRT6C, KRT16, or KRT17.

Introduction

Pachyonychia congenita (PC) is a rare autosomal dominant genodermatosis which is caused by a mutation in any one of the five keratin genes, KRT6A, KRT6B, KRT6C, KRT16, or KRT17.[1] There are an estimated 5000–10,000 cases worldwide.[2] PC affects all ethnic backgrounds and the same mutations are found among various nationalities. More than 100 distinct mutations have now been identified resulting in an array of PC phenotypes (www.pachyonychia.org). PC is characterized by a triad of dystrophy of some or all toenails and/or fingernails, plantar keratoderma, and plantar pain. Other associated features are cysts of various types, follicular hyperkeratosis, oral leukokeratosis, hyperhidrosis, and natal teeth.[3] Historically, PC was divided into two subgroups, PC-1 and PC-2.[45] However, this classification is based on case series and isolated case reports. PC has features overlapping with other palmoplantar keratodermas (PPKs), but the modern-day discriminator is mutational analysis. Over the past 10 years, the PC project (www.pachyonychia.org) has gathered data on over 700 genetically confirmed PC patients, which have been compiled in the International PC Research Registry (IPCRR). Based on these more extensive data, the classification was revised in 2011 according to keratin mutation subtypes, i.e., PC-K6a, PC-K6b, PC-K6c, PC-K16, and PC-K17 that correspond to mutations in the KRT6A, KRT6B, KRT6C, KRT16, and KRT17 genes, respectively.[36] The clinical features of all five subtypes overlap and although there are some differences that distinguish between them, confirmation by genetic testing provides the definitive diagnosis. PC-K17 individuals have multiple cysts that develop at puberty, and milia are often present in young children. The presence of natal teeth indicates PC-K17 (though not all PC-K17 cases have natal teeth). Plantar pain in PC-K17 is highly variable between individuals. Those with PC-K6a, in general, have high levels of plantar pain, 20/20 nail involvement, and oral leukokeratosis. PC-K6b and PC-K6c mostly present with milder and less nail involvement and milder plantar keratoderma than other subtypes. PC-K16 individuals have painful plantar keratoderma and more palmar keratoderma. Nail involvement varies from extremely hypertrophic nails to few or no nails involved and certain mutations in KRT16, p. Asn125Ser and p. Arg127Cys, are known to be associated with mild or no nail involvement.[7] These four families with mutations in KRT17 are the first-reported cases from India with PC to be reported with genetic testing to confirm the clinical diagnosis.

Case Report

The proband from Family 1 was a 30-year-old female who presented with complaints of multiple cysts on the neck, trunk, axillae, extremities, and abdomen [Figure 1] with thickened nails and plantar keratoderma. The onset of skin lesions began at the age of 18 years. The patient gave history of natal teeth. Her daughter was similarly affected [Figure 2]. Features were noted when she was younger which could have been due to increased awareness of the disease within the family. The cutaneous features and clinical course of the disease were in keeping with PC as described in literature, although plantar pain was strikingly absent. Plantar pain is the most common finding in patients of PC and has been reported in nearly 90% of patients above the age of 10 years.[3] For all cases in this report, genomic DNA was extracted from peripheral blood leukocytes using standard procedures or from saliva collected in an Oragene DNA sample collection kit (DNA Genotek, Ontario, Canada) and extracted according to the manufacturer's protocol. Samples were obtained by the IPCRR with informed consent and ethical approval from the Western Institutional Review Board that complies with principles of the Helsinki Accord. Mutation analysis was performed as described by Wilson et al. in 2014.[1] A heterozygous missense mutation in KRT17, K17 p. Met88 Lys, c.263T>A, was identified in Family 1 in both the proband and her daughter; this is a previously reported mutation.[8]
Figure 1

Mild to severe plantar keratoderma (a) Family 1 (affected daughter) and (b) Family 3. Thickened finger and toenails, (c) Family 1 (affected daughter), (d) Family 4, (e) Family 3, and (f) Family 2

Figure 2

Multiple cysts present on the neck, axillae, and abdomen; (a and c) proband from Family 1, (b and d) the affected individual from Family 2. (e) Affected individual from Family 4 showing natal teeth

Mild to severe plantar keratoderma (a) Family 1 (affected daughter) and (b) Family 3. Thickened finger and toenails, (c) Family 1 (affected daughter), (d) Family 4, (e) Family 3, and (f) Family 2 Multiple cysts present on the neck, axillae, and abdomen; (a and c) proband from Family 1, (b and d) the affected individual from Family 2. (e) Affected individual from Family 4 showing natal teeth A 37-year-old female from Family 2 presented as a spontaneous case with thickened finger and toenails, plantar keratoderma, mild plantar pain, multiple cysts, and natal teeth [Figures 1 and 2]. She had no oral leukokeratosis or follicular keratosis. A previously reported heterozygous missense mutation was identified, K17 p. Leu95Proc.284T>C.[19] In Family 3, a 30-year-old male presented with painful plantar keratoderma, palmar keratoderma, thickening of all finger and toenails, oral leukokeratosis, natal teeth, and multiple cysts [Figure 2]. By direct DNA sequence analysis, we identified previously reported heterozygous missense mutation, K17 p. Asn92Serc.275AG; this mutation has been identified in more than 25 families.[19] A 6-month-old girl from Family 4 presented with multiple milia on her face and thickening of all finger and toenails [Figure 2]. She had two natal teeth but no oral leukokeratosis [Figure 1]. Her parents were unaffected. She was found to have a previously reported heterozygous missense mutation in KRT17, K17 p.Leu99Pro, c.296T>C.[19]

Discussion

Here, we report mutations in KRT17 as the cause of PC in all 4 families (5 individuals) from India. For individuals from Families 1, 2, and 3, the predominant feature and main complaint was multiple cysts [Table 1]. Typical of young children with PC-K17, the young girl in Family 4 had multiple milia and will likely develop cysts around puberty. Thickening of the finger and toenails started very early in childhood, and for each of the five cases, all twenty nails were affected [Table 1]. Two of the four adults reported plantar pain, and in one case, this was extremely painful often requiring medication. These features along with the presence of natal teeth are very typical of the PC-K17 form of PC [Table 1]. Summary of the clinical data of the five Indian cases and 109 (including these five cases) genetically confirmed PC-K17 cases in the IPCRR is shown in Table 2. All these mutations have been previously reported in different ethnic populations.
Table 1

Summary of the clinical data and mutations of the 5 Indian cases

Table 2

Summary of the clinical data of the 5 Indian cases and 109 (including these 5 cases) genetically confirmed pachyonychia congenita-K17 cases in the International Pachyonychia Congenita Research Registry

Summary of the clinical data and mutations of the 5 Indian cases Summary of the clinical data of the 5 Indian cases and 109 (including these 5 cases) genetically confirmed pachyonychia congenita-K17 cases in the International Pachyonychia Congenita Research Registry The lack of awareness regarding this disease and the paucity of genetic testing in suspected cases could be one of the reasons for the rarity of reported cases. We hope that this report will heighten awareness among dermatologists in developing countries to consider a diagnosis of PC when a patient presents with the triad of nail involvement, plantar pain, and PPK often accompanied with cysts, follicular hyperkeratosis, oral leukokeratosis, hyperhidrosis, and natal teeth and to confirm the initial diagnosis by genetic testing. PC Project provides free services including physician consultations, genetic testing and other support services to PC patients worldwide. Nearly 15% of those clinically diagnosed with PC and referred to the IPCRR (www.pachyonychia.org) are found to have a condition other than PC. This observation demonstrates the importance of obtaining a genetic confirmation of the disorder. The expanding database of molecular and clinical data collected by the IPCRR is of huge benefit in the development of future clinical trials.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest. What is new? Previously reported mutations in KRT17 also occur in the Indian population The patient advocacy group, pachyonychia congenita (PC) project (www.pachyonychia.org) provides many services for PC patients worldwide including free genetic testing Confirmation of a clinical diagnosis allows for appropriate genetic counseling and management of the disorder.
  8 in total

Review 1.  Challenges in developing therapies for rare diseases including pachyonychia congenita.

Authors:  Roger L Kaspar
Journal:  J Investig Dermatol Symp Proc       Date:  2005-10

2.  Pachyonychia congenita; a report of six cases in one family, with a note on linkage data.

Authors:  A D M Jackson; S D Lawler
Journal:  Ann Eugen       Date:  1951-01

3.  A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.

Authors:  Mark J Eliason; Sancy A Leachman; Bing-jian Feng; Mary E Schwartz; C David Hansen
Journal:  J Am Acad Dermatol       Date:  2012-01-20       Impact factor: 11.527

Review 4.  The phenotypic and molecular genetic features of pachyonychia congenita.

Authors:  W H Irwin McLean; C David Hansen; Mark J Eliason; Frances J D Smith
Journal:  J Invest Dermatol       Date:  2011-03-24       Impact factor: 8.551

5.  The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases.

Authors:  Ildiko Szeverenyi; Andrew J Cassidy; Cheuk Wang Chung; Bernett T K Lee; John E A Common; Stephen C Ogg; Huijia Chen; Shu Yin Sim; Walter L P Goh; Kee Woei Ng; John A Simpson; Li Lian Chee; Goi Hui Eng; Bin Li; Declan P Lunny; Danny Chuon; Aparna Venkatesh; Kian Hoe Khoo; W H Irwin McLean; Yun Ping Lim; E Birgitte Lane
Journal:  Hum Mutat       Date:  2008-03       Impact factor: 4.878

6.  A novel point mutation of keratin 17 (KRT17) in a Japanese family with pachyonychia congenita type 2: an RNA-based genetic analysis using a single hair bulb.

Authors:  T Tsuda; C Ishikawa; N Nakagawa; H Konishi; M Tarutani; M Matsuki; K Yamanishi
Journal:  Br J Dermatol       Date:  2008-06-28       Impact factor: 9.302

7.  Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations.

Authors:  Teresa Fu; Sancy A Leachman; Neil J Wilson; Frances J D Smith; Mary E Schwartz; Jean Y Tang
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

8.  The molecular genetic analysis of the expanding pachyonychia congenita case collection.

Authors:  N J Wilson; E A O'Toole; L M Milstone; C D Hansen; A A Shepherd; E Al-Asadi; M E Schwartz; W H I McLean; E Sprecher; F J D Smith
Journal:  Br J Dermatol       Date:  2014-08-06       Impact factor: 9.302

  8 in total
  2 in total

1.  Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.

Authors:  Albert G Wu; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2021-02-05

2.  Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic cancer cells.

Authors:  Peng Chen; Zhengchao Shen; Xiaosan Fang; Guannan Wang; Xiaoming Wang; Jun Wang; Shihang Xi
Journal:  Oncol Lett       Date:  2020-03-20       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.